大麻素CB2受体阳性全调节器EC21a表现出复杂的体外药理学
Aidong Qi1, Xueqing Han1, Marc Quitalig1
1Department of Pharmacology and Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, USA.
Journal of receptor and signal transduction research
|November 22, 2024
概括
研究人员研究了向大麻素2型 (CB2) 受体的化合物,作为精神分裂症的潜在治疗方法. 然而,被测试的化合物EC21a在CB2受体上表现出复杂的逆激素活性,使其治疗潜力复杂化.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 精神分裂症是一种复杂的大脑疾病,具有积极,消极和认知症状.
- 之前的研究表明,M4肌糖和mGlu1受体的阳性全调节器 (PAM) 通过大麻素2型 (CB2) 受体激活来实现抗精神病疗效.
- 这表明CB2受体调节是精神分裂症的潜在治疗策略.
研究的目的:
- 描述一种2-型大麻素 (CB2) 受体阳性全调节器 (PAM) 支架,以化合物EC21a为例.
- 评估EC21a作为开发新型精神分裂症治疗方法的起点的潜力.
- 研究EC21a和相关化合物在CB2和CB1受体上的药理特征.
主要方法:
- 采用了两个互补的测定方法:受体介导的酸化解和GIRK通道激活.
- 描述了化合物EC21a和相关类似物在CB2和CB1受体上的全性活性.
- 评估了选择的试验中化合物的剂量反应关系和疗效.
主要成果:
- 化合物EC21a表现出复杂的药理学,在两项测试试验中都作为CB2受体的全逆agonist.
- 在CB1受体上,EC21a表现出混合的全激素激剂/负全调节器特征,这种特征依赖于试验.
- 相关化合物也起到CB2逆激动剂的作用,这表明在支架内存在一致的药理学趋势.
结论:
- 测试的CB2向化合物,包括EC21a,显示复杂且可能依赖测试的药理学特征.
- 在CB2受体的逆激动性挑战了CB2激动性对精神分裂症治疗益处的初始假设.
- 这些发现强调了需要仔细解释体内研究的必要性,并表明治疗开发需要进一步优化.
更多相关视频
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
202
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
202
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
Drug-Receptor Interaction: Agonist
2.4K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.4K
Drug-Receptor Interactions
5.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.0K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
163
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
163
Dose-Response Relationship: Potency and Efficacy
4.2K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.2K


